Metformin (MET) and atorvastatin (ATO) are promising treatments for COVID-19. This review
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …

This review article explores the potential of metformin, a medication commonly used for type
2 diabetes, as an antiviral and anti-inflammatory agent in the context of coronavirus disease …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections present with
increased disease severity and poor clinical outcomes in diabetic patients compared with …

The novel coronavirus disease 2019 (COVID‐19), is currently the leading threat to public
health and a huge challenge to the healthcare systems across the globe and caused by …

The COVID-19 pandemic caused by the coronavirus SARS-CoV-2 has become a serious
challenge for medicine and science. Analysis of the molecular mechanisms associated with …

The pandemic of coronavirus disease 2019 (COVID-19), a disease which causes severe
lung injury and multiple organ damage, presents an urgent need for new drugs. The case …

SARS-CoV-2 infection has been a major threat to human health and a huge challenge to
Medicine. In only two years, COVID-19 affected> 350 million people, causing> 5.6 million …

Coronavirus Disease 2019 (COVID-19), caused by a new strain of coronavirus called
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was declared a …

Introduction Early treatment for SARS-CoV-2 infection is essential to limit the clinical
progression of COVID-19. However, limited therapeutic options are available for standard …

Approximately 4 years into the coronavirus disease 2019 (COVID-19) pandemic, available
treatment options for outpatients have a mixed track record. The most notable success is …